Maharashtra recorded the maximum number of deaths due to serious adverse events (SAEs) during drug trials, while Madhya Pradesh saw the least number of such deaths.

According to data disclosed by the Drug Controller-General of India, during the 49-month period (January 2008-January 2012), the country recorded 2,061 drug trial-related deaths. But data has been given only for 1,603 of the 2,061 deaths.